HIGH-VOLUME · HOSP-MID
dapagliflozin Side Effects
dapagliflozin (also sold as Farxiga) is HIGH-VOLUME in this FAERS book #140 of 524 by FAERS report count. Signature opener: HOSP-MID - 28.4% mention hospitalization (14,338 reports).
Data updated 2026-05-15
- 50,521
- FAERS reports
FAERS voluntary reports, 2008 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.
dapagliflozin: 28.4% mention hospitalization (14,338 reports). Death stamp DEATH-HEAVY; volume band HIGH-VOLUME #140 of 524 by FAERS report count.
High-report extract for dapagliflozin (Farxiga): 50,521 FAERS rows (2008-2025). Top named reactions: DEATH, FATIGUE, NAUSEA. Outcome stamps DEATH-HEAVY · HOSP-MID · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.
Counts from the openFDA FAERS extract (2008–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
DEATH leads 7,017 of 50,521 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (9,055 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (8,602 reports, 17.0%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 7,012 |
| CARDIAC FAILURE | 189 |
| ACUTE KIDNEY INJURY | 150 |
| PNEUMONIA | 145 |
| DYSPNOEA | 98 |
| HYPOTENSION | 86 |
| MYOCARDIAL INFARCTION | 84 |
| RENAL FAILURE | 84 |
| CARDIAC ARREST | 83 |
| DIARRHOEA | 80 |
| SEPSIS | 77 |
| DEHYDRATION | 76 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 69 |
| SEPTIC SHOCK | 69 |
| LACTIC ACIDOSIS | 67 |
| ASTHENIA | 66 |
| DRUG INTERACTION | 63 |
| VOMITING | 63 |
| URINARY TRACT INFECTION | 60 |
Reactions in Hospitalization Reports
Hospitalization mid-share (14,338, 28.4%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| ACUTE KIDNEY INJURY | 1,305 |
| DIABETIC KETOACIDOSIS | 1,061 |
| DYSPNOEA | 866 |
| NAUSEA | 759 |
| VOMITING | 724 |
| DIARRHOEA | 715 |
| DEHYDRATION | 682 |
| HYPOTENSION | 604 |
| URINARY TRACT INFECTION | 600 |
| CARDIAC FAILURE | 598 |
| DIZZINESS | 572 |
| FATIGUE | 545 |
| PNEUMONIA | 514 |
| ASTHENIA | 492 |
| MALAISE | 490 |
| FALL | 480 |
| EUGLYCAEMIC DIABETIC KETOACIDOSIS | 426 |
| WEIGHT DECREASED | 400 |
| BLOOD GLUCOSE INCREASED | 392 |
How to read dapagliflozin FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-MID)
FAERS holds 50,521 voluntary reports linked to dapagliflozin (Farxiga), 2008-2025. Death is listed on 8,602 (17.0%). Hospitalization appears on 14,338 (28.4%). Top co-reported indication: Product Used For Unknown Indication.
CASELOAD books overweight common drugs and loud reporting cultures; HOSP-MID is the page opener, not a per-patient risk.
Read with dapagliflozin
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 51,370 FAERS cases (Δ 849 heavier vs dapagliflozin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 49,370 FAERS cases (Δ 1,151 lighter vs dapagliflozin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 51,859 FAERS cases (Δ 1,338 heavier vs dapagliflozin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 52,302 FAERS cases (Δ 1,781 heavier vs dapagliflozin); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 45.1 pp vs dapagliflozin's DEATH-HEAVY): CASELOAD · HOSP-MID.
dapagliflozin stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload CASELOAD and the label guide.